Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor

Medicine and Dentistry

• Camptothecin 100%
• Topotecan 100%
• Cisplatin 66%
• Radiation 66%
• Cytotoxicity 50%
• Tumor Cell 50%
• Topoisomerase Inhibitor 50%
• Hyperthermia 50%
• Tumor Progression 33%
• Drug 33%
• Chemotherapeutic Agent 33%
• Thermal Radiation 33%
• Neoplasm 16%
• Toxicity 16%
• Combination Therapy 16%
• Breast Carcinoma 16%
• Loglinear Model 16%
• Cell Killing 16%
• Cell Survival 16%
• Carcinoma Cell 16%
• Drug Exposure 16%
• Colony Forming Unit GM 16%
• Cells 16%
• Assay 16%
• Therapeutic Procedure 16%
• Bone Marrow 16%
• Epithelial Mesenchymal Transition 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Camptothecin 100%
• Topotecan 100%
• Cisplatin 66%
• Cytotoxicity 50%
• DNA Topoisomerase Inhibitor 50%
• Hyperthermia 50%
• Tumor Growth 33%
• Drug 33%
• Neoplasm 16%
• Toxicity 16%
• Breast Carcinoma 16%
• Murine 16%